Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5

Jeffrey M. Chambliss, Sanjiv Sur, Julia Tripple

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Purpose of review Asthma and COPD represent heterogeneous disorders with broad ranging impact on patients and health systems. This review focuses on evidence for early attempts at understanding their pathogenesis by the British and Dutch hypotheses. It also addresses the role of eosinophils, IL-5, and biologics targeting these pathways in asthma and COPD. Recent findings Among asthma and COPD patients, clusters exist based on phenotypic and biologic markers allowing for further understanding of endotypes. Recent studies suggest the role of eosinophils and optimal therapies for each condition may be different. Summary Although patients with ACOS or overlap symptoms may be an exception, overall there appears to be more evidence supporting that asthma and COPD are distinct processes. Targeting eosinophils with anti-IL-5 therapy appears to be an exciting pathway in the properly selected patient with asthma and recent data also supports its use in COPD.

Original languageEnglish (US)
Pages (from-to)26-31
Number of pages6
JournalCurrent Opinion in Allergy and Clinical Immunology
Volume18
Issue number1
DOIs
StatePublished - Feb 1 2018

Fingerprint

Interleukin-5
Chronic Obstructive Pulmonary Disease
Asthma
Eosinophils
Biological Products
Biomarkers
Health
Therapeutics

Keywords

  • asthma
  • chronic obstructive pulmonary disease
  • eosinophils
  • interleukin-5

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5. / Chambliss, Jeffrey M.; Sur, Sanjiv; Tripple, Julia.

In: Current Opinion in Allergy and Clinical Immunology, Vol. 18, No. 1, 01.02.2018, p. 26-31.

Research output: Contribution to journalReview article

@article{226763a901ee4a4984ee59439df60d68,
title = "Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5",
abstract = "Purpose of review Asthma and COPD represent heterogeneous disorders with broad ranging impact on patients and health systems. This review focuses on evidence for early attempts at understanding their pathogenesis by the British and Dutch hypotheses. It also addresses the role of eosinophils, IL-5, and biologics targeting these pathways in asthma and COPD. Recent findings Among asthma and COPD patients, clusters exist based on phenotypic and biologic markers allowing for further understanding of endotypes. Recent studies suggest the role of eosinophils and optimal therapies for each condition may be different. Summary Although patients with ACOS or overlap symptoms may be an exception, overall there appears to be more evidence supporting that asthma and COPD are distinct processes. Targeting eosinophils with anti-IL-5 therapy appears to be an exciting pathway in the properly selected patient with asthma and recent data also supports its use in COPD.",
keywords = "asthma, chronic obstructive pulmonary disease, eosinophils, interleukin-5",
author = "Chambliss, {Jeffrey M.} and Sanjiv Sur and Julia Tripple",
year = "2018",
month = "2",
day = "1",
doi = "10.1097/ACI.0000000000000409",
language = "English (US)",
volume = "18",
pages = "26--31",
journal = "Current Opinion in Allergy and Clinical Immunology",
issn = "1528-4050",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5

AU - Chambliss, Jeffrey M.

AU - Sur, Sanjiv

AU - Tripple, Julia

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Purpose of review Asthma and COPD represent heterogeneous disorders with broad ranging impact on patients and health systems. This review focuses on evidence for early attempts at understanding their pathogenesis by the British and Dutch hypotheses. It also addresses the role of eosinophils, IL-5, and biologics targeting these pathways in asthma and COPD. Recent findings Among asthma and COPD patients, clusters exist based on phenotypic and biologic markers allowing for further understanding of endotypes. Recent studies suggest the role of eosinophils and optimal therapies for each condition may be different. Summary Although patients with ACOS or overlap symptoms may be an exception, overall there appears to be more evidence supporting that asthma and COPD are distinct processes. Targeting eosinophils with anti-IL-5 therapy appears to be an exciting pathway in the properly selected patient with asthma and recent data also supports its use in COPD.

AB - Purpose of review Asthma and COPD represent heterogeneous disorders with broad ranging impact on patients and health systems. This review focuses on evidence for early attempts at understanding their pathogenesis by the British and Dutch hypotheses. It also addresses the role of eosinophils, IL-5, and biologics targeting these pathways in asthma and COPD. Recent findings Among asthma and COPD patients, clusters exist based on phenotypic and biologic markers allowing for further understanding of endotypes. Recent studies suggest the role of eosinophils and optimal therapies for each condition may be different. Summary Although patients with ACOS or overlap symptoms may be an exception, overall there appears to be more evidence supporting that asthma and COPD are distinct processes. Targeting eosinophils with anti-IL-5 therapy appears to be an exciting pathway in the properly selected patient with asthma and recent data also supports its use in COPD.

KW - asthma

KW - chronic obstructive pulmonary disease

KW - eosinophils

KW - interleukin-5

UR - http://www.scopus.com/inward/record.url?scp=85039756315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039756315&partnerID=8YFLogxK

U2 - 10.1097/ACI.0000000000000409

DO - 10.1097/ACI.0000000000000409

M3 - Review article

C2 - 29257776

AN - SCOPUS:85039756315

VL - 18

SP - 26

EP - 31

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

SN - 1528-4050

IS - 1

ER -